key: cord-0855456-zl9nouz4
authors: Reschen, Michael E.; Bowen, Jordan; Novak, Alex; Giles, Matthew; Singh, Sudhir; Lasserson, Daniel; O’Callaghan, Christopher A.
title: Impact of the COVID-19 pandemic on emergency department attendances and acute medical admissions
date: 2021-11-20
journal: BMC Emerg Med
DOI: 10.1186/s12873-021-00529-w
sha: 8fce83fc32b06a2df60931cca1e0632cfd250ca6
doc_id: 855456
cord_uid: zl9nouz4

BACKGROUND: To better understand the impact of the COVID-19 pandemic on hospital healthcare, we studied activity in the emergency department (ED) and acute medicine department of a major UK hospital. METHODS: Electronic patient records for all adult patients attending ED (n = 243,667) or acute medicine (n = 82,899) during the pandemic (2020–2021) and prior year (2019) were analysed and compared. We studied parameters including severity, primary diagnoses, co-morbidity, admission rate, length of stay, bed occupancy, and mortality, with a focus on non-COVID-19 diseases. RESULTS: During the first wave of the pandemic, daily ED attendance fell by 37%, medical admissions by 30% and medical bed occupancy by 27%, but all returned to normal within a year. ED attendances and medical admissions fell across all age ranges; the greatest reductions were seen for younger adults in ED attendances, but in older adults for medical admissions. Compared to non-COVID-19 pandemic admissions, COVID-19 admissions were enriched for minority ethnic groups, for dementia, obesity and diabetes, but had lower rates of malignancy. Compared to the pre-pandemic period, non-COVID-19 pandemic admissions had more hypertension, cerebrovascular disease, liver disease, and obesity. There were fewer low severity ED attendances during the pandemic and fewer medical admissions across all severity categories. There were fewer ED attendances with common non-respiratory illnesses including cardiac diagnoses, but no change in cardiac arrests. COVID-19 was the commonest diagnosis amongst medical admissions during the first wave and there were fewer diagnoses of pneumonia, myocardial infarction, heart failure, cellulitis, chronic obstructive pulmonary disease, urinary tract infection and other sepsis, but not stroke. Levels had rebounded by a year later with a trend to higher levels of stroke than before the pandemic. During the pandemic first wave, 7-day mortality was increased for ED attendances, but not for non-COVID-19 medical admissions. CONCLUSIONS: Reduced ED attendances in the first wave of the pandemic suggest opportunities for reducing low severity presentations to ED in the future, but also raise the possibility of harm from delayed or missed care. Reassuringly, recent rises in attendance and admissions indicate that any deterrent effect of the pandemic on attendance is diminishing. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12873-021-00529-w.

In 2020 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) caused a worldwide pandemic of COVID-19 disease resulting in substantial excess mortality and global disruption to healthcare and social care. The first major peak in COVID-19 cases in England occurred between March and May in 2020 and prompted a national lockdown. Lockdown measures were adjusted during the pandemic and widespread vaccination in 2021 triggered relaxation of the restrictions. During the pandemic, healthcare was rapidly restructured in anticipation of predicted needs [1] . This included redeployment of people and resources, especially to acute general medicine, emergency medicine and critical care, reductions in non-COVID-19 research activity, reductions in elective procedures, and increased use of remote telephone or video consultations [2, 3] .

Reports of reductions in hospitalization for non-COVID-19 acute illnesses have raised concerns that patients may not have attended hospital for an acute illness and might subsequently experience increased morbidity or mortality as a result [4] [5] [6] [7] [8] [9] . Factors influencing hospital attendance during the pandemic may have included fear of acquiring COVID-19 infection, a desire to reduce the pressure on hospitals or a higher threshold among referring and receiving clinicians for hospital review or admission. Conversely, others have suggested patients avoiding ED had more minor illness and this had a beneficial effect by reducing crowding in ED [10] .

In the UK, acute hospital care is provided by direct presentation of patients to the emergency department (ED) or referral of patients by their primary care general practitioner or paramedics to the hospital [11] . We sought to understand both the COVID-19 and non-COVID-19 activity in the ED and the acute medicine department and how this changed across the course of the pandemic. It is important to understand both the dramatic changes that occurred during the first wave of the pandemic and the subsequent patterns of acute care usage after this early phase.

The aim of our study was to determine the clinical characteristics of emergency department attendances and medical admissions during the COVID-19 pandemic and whether particular groups were under-represented during the pandemic peaks and the time frame of any changes.

We identify and characterise major changes in ED attendances and in medical admissions during the pandemic and highlight changes in physiological severity, patterns of diagnoses, and outcomes including mortality. These findings demonstrate the profound impact of a pandemic on urgent care, even for non-pandemic illness, and will form a foundation for planning to minimise the impact in the future.

We extracted data from the hospital electronic health record (EHR) for all ED patients aged 18 or over from the Oxford University Hospitals NHS Foundation Trust (John Radcliffe and Horton sites) between 17th March 2019 and 12th July 2021 (n = 243,667). We extracted data for medical admissions from the EHR between 1st January 2019 and 18th August 2021 and pruned the analysis to 17th March to 18th July 2021 (n = 82,899). The longer time period for admissions compared to ED attendances allows proper analysis of medical patients who were inpatients during the period of interest but admitted or discharged outside this time period. ED attendances and acute medicine patient data incorporate critical care and high dependency unt (HDU) admissions because these admissions pass through ED or for medical patients remain under the duty medical physician. Day-case attendances (consisting of procedural admissions for e.g., endoscopy or bronchoscopy) were removed from the data by filtering out admissions to a day-case unit location or where the admission method was 'planned', 'booked', or 'elective'. For analysis of acute medical patients, the hospital attendances were subdivided into 'medical attendances' where the patient was discharged directly from the ambulatory emergency care unit (AEC) and into 'medical admissions' where the patient was admitted directly to a bed-based pathway or admitted to a bed-based pathway from the AEC. At our institution medical admissions mostly occur through the emergency medical assessment unit (EAU) but can also occur directly from ED to medical wards or directly from the ambulance service to cardiology for suspected ST-elevation myocardial infarction.

Clinical ED data are recorded according to the UK emergency care dataset (ECDS) parameters [12] . The ED diagnosis is recorded in real time by the clinician selecting from a curated list of SNOMED terms. We modified this list by adding diagnostic codes for COVID-19 and categorizing COVID-19 into the 'respiratory' group of diseases in group 2 of the ECDS diagnostic tree (Supplementary file ECDS datatable of ECDS codes and groupings).

For acute medical admissions the diagnosis of COVID-19 was derived from the primary diagnosis data field using ICD-10 codes of U07.1 (COVID-19, virus identified) and U07.2 (COVID-19, virus not-identified). The medical diagnoses are recorded by professional medical coders after the admission is completed using aggregated data from the EHR. Inpatient COVID-19 diagnoses in our institution are generally made by a consultant using a combination of clinical data, PCR testing, lateral flow testing and chest X-ray or CT findings. For ED patients, PCR testing was not widely available during the first wave of the pandemic.

Mortality data were obtained from the EHR and by querying the NHS Digital Personal Demographics Service Database using the Demographics Batch Service [13] .

Our hospitals serve a population of around 650,000. The UK containment phase of the pandemic ended on 12th March 2020 and from 16th March onwards a 'lockdown' was officially advised and enforced from 23rd March 2020. We defined the first wave of the pandemic period as from 17th March 2020 to 31st May 2020 and this captures the major first peak of COVID-19 in the UK. Patients with suspected COVID-19 (fever, respiratory symptoms) or confirmed COVID-19 are assigned into side-rooms, grouped bays, or designated wards according to a traffic light system of Green (not COVID-19), Amber (suspected COVID- 19) or Blue (confirmed . Further details on COVID-19 infection control and pathways at our Institution are published elsewhere [14] . We define the second wave of the pandemic period as from 26th November 2020 to 10th February 2021. For numerical comparisons we used a prepandemic period in 2019 that matched the first pandemic peak and a late-pandemic period matching the equivalent time period in 2021 one calendar year after the first peak period.

Analysis was undertaken using R [15] . Rolling averages over time were calculated using the 'rollmean' function of the zoo (v1.8.9) package in R [16] . A centred rolling window of 14 days was used for daily deaths and daily medical admissions and a window of 28 days for all other plots. ED patients were considered to be 'Admitted' if admitted from ED for more than 24 h or 'Discharged' if discharged from ED directly or within 24 h of attending hospital. For medical attendances diagnoses were stratified as COVID-19 if the primary diagnosis code was either U07.1 or U07.2 and as non-COVID-19 for all other primary diagnoses.

For age group analysis patients were stratified into 10 age groups of equal time width using the binning function in the R package dlookr [17] . For categorical variables including gender and ethnicity, the difference in distribution between the pre-pandemic period and pandemic first wave peak period was compared with a chisquared test and if significant, then a row-wise proportion test with multiple testing correction to evaluate the difference between categories using the prop test function in the rstatix package [18] . To calculate distance from a patient's domiciliary address to hospital we used the code for the UK census area of their address, termed the 'lower layer super output area' (LSOA) and obtained the latitude and longitude for the centroid position of the LSOA from the 2011 Office of National Statistics Census data [19] . To obtain the latitude and longitude from the Northing and Easting positions in the census data we converted them using the web tool https:// gridreferencefinder.com/batchConvert/batchConvert. php. To calculate the straight-line distance from the hospital to the respective centroid coordinate we used a webtool distance calculator: https://stevemorse.org/ nearest/distancebatch.html. The significance comparison of distance was calculated with a Student's t test. A deprivation decile was assigned by matching the LSOA code to the Index of Multiple Deprivation data from the English Indices of Deprivation 2015 [20] . A value of 1 indicates the most deprived area and an overall chi squared test was performed between comparator groups and if significant then a row-wise proportion test.

For medical patients, co-morbidities were determined from the ICD10 codes for secondary diagnoses up to a depth of 50 co-morbidities. A combined co-morbidity score was calculated according to the mean weighted Elixhauser score system using the R package 'comorbidity' [21, 22] . We amalgamated the comorbidity R package categories of 'hypertension' and 'hypertensionuncomplicated' as well as 'diabetes' and 'diabetes-complicated'. Alcoholic liver disease was parsed separately using an ICD10 code of K70. To calculate a NEWS2 score (National Early Warning Score 2) we used the first set of observations including temperature, heart rate, systolic/diastolic blood pressure, peripheral oxygen saturation (without correction for chronic type 2 respiratory failure status), Glasgow Coma Score and the use of supplemental oxygen [23] . We report mean scores compared using a Wilcoxon Rank sum test, and calculated incidence rate ratios for each of the 4 NEWS2 alert categories. NEWS2 score were binned into the NEWS2 clinical risk alert levels whereby a score of 0-4 = "low", unless any individual category is 3 in which case = "lowmedium", 5-6 = "medium", 7+ = "high". The number of attendances/admissions without available observations is shown in supplementary tables referred to in the Results. To calculate an incidence rate ratio between the pandemic and pre-pandemic period we used a Poisson regression model of daily counts of each category implemented by the R mfx package 'poisonirr' [7, 24] . The proportion of patients using oxygen was compared with a chi-squared test.

For the ED presenting complaint and primary diagnosis we selected the 10 commonest diagnoses across the whole dataset. The ED primary diagnosis data is displayed at the 2nd group level of the ECDS system (with COVID-19 grouped in 'Respiratory'). For the primary diagnosis for medical admissions, we selected the 10 commonest primary diagnoses at the ICD-10 tier level of 3 alphanumeric characters. Statistical analysis was performed using incidence rate ratios as described above. For ED data we also show a table of manually selected diagnoses at the most granular level of diagnosis.

Student's t-test was used to analyse ED length of stay. For ED mortality we calculated a mortality rate using the number of patients who died during their ED attendance or before leaving hospital if they were admitted and applied a chi-squared test of the proportion. For medical patients we calculated the mortality rate during admission and compared the proportion of admissions with mortality using a chi-squared test.

The study formed part of an institutional service evaluation using retrospectively collected anonymized routine clinical data and was deemed not to require further ethical approval or informed consent from patients.

Impact on ED attendances and acute medical admissions ED attendances declined sharply following the first UK death from COVID-19, the reporting of over 1000 UK cases, and the World Health Organisation (WHO) declaring a pandemic ( Fig. 1 ). During the first wave of the pandemic, there was a 37% fall in total ED attendances to 195 per day from 309 per day in the matched period of the preceding year and this rose to 296 per day in the matched period of 2021.

The daily number of hospital admissions arising from all ED attendances was 50 in the matched period in Fig. 1 Daily ED attendance over time with major event time points labelled (WHO=World Health Organization, PHEIC=Public health emergency of international concern, 3 T system = 3-tiered regional lockdown system) Fig. 2A) . The timeline shows attendances that did not lead to admission dipped during the periods of national peaks in COVID-19 cases, but then rose to the highest levels during the summer of 2021 after most lockdown measures had ended ( Fig. 2A) .

Daily attendances to the acute medical department fell by 30% from 83 in the matched period in 2019 to 58 during the first wave and rose to 96 in the matched period in 2021 (Fig. 2B) . Acute medical admissions per day also fell by 28% from 56 in the matched period of 2019 to 40 in the first wave, rising to 56 in the matched period in 2021. We further selectively analysed medical patients who were admitted into a bed-based pathway because planning inpatient bed use during the pandemic was a key challenge to ensure that the hospital was not overwhelmed. The first peak in COVID-19 admissions occurred in the week commencing 29th March 2020, when there were 113 (245 non-COVID-19 admissions) and the second peak occurred in the week commencing 3rd January 2021 with 266 (455 non-COVID-19 admission) (Fig. 2B ).

The number of medical inpatients in the hospital each day fell from a mean of 334 in the pre-pandemic period to 244 in the first peak, 376 in the second peak and 329 in 2021 (Fig. 2C) . Overall, the percentage of medical beds occupied by patients with COVID-19 rose to 26.5% during the first peak and 36.2% in the second peak.

A significant reduction in total ED attendances was observed across all age groups in the first wave of the pandemic with the biggest absolute and relative reductions among the two youngest age bands (Fig. 3A , Table 1 , Supplementary Table 1 ). The timeline shows an increase in attendances for the younger age groups towards prepandemic levels by the summer of 2020. The mean age increased significantly from 50 in the pre-pandemic period to 53 in the pandemic first wave (Supplementary Table 1 ). There was no change in the distribution of gender or deprivation indices during the pandemic period first wave compared to the matched prepandemic period in 2019 (Supplementary Table 1 ). The Table 1 ). In contrast to ED attendances, most medical admissions in the pre-pandemic period were in the older age groups (Fig. 3B , Table 2, Supplementary Table 2 ). During the first wave pandemic period the absolute numbers of medical admissions fell across all ages ( Table 2 ). The mean age was significantly lower at 69 in the pandemic period (non-COVID-19) compared to 71 in the prepandemic period (Supplementary Table 2 ). There was no difference in mean age within the pandemic first wave between non-COVID-19 (69) and COVID-19 admissions (69). There was no significant difference in the gender or deprivation profiles between the prepandemic period and the pandemic first wave period (Supplementary Table 2 ). Among non-COVID-19 admissions during the pandemic 1st wave peak there was in increase in the proportion with ethnicity 'Other -Not stated'. Compared with non-COVID-19 patients, Table 2 ). The mean distance from the patient's home to the hospital for all medical admissions (including COVID-19) did not differ significantly from 17.6 km in the pre-pandemic period to 16.4 km during the pandemic period. The mean Elixhauser co-morbidity score for non-COVID-19 medical admissions increased from 5.3 before the pandemic to 7.1 during the pandemic (p < 0.001) and within the pandemic first wave did not differ significantly from that of 6.8 for COVID-19 [25] . Patients admitted with non-COVID-19 diagnoses during the pandemic first wave had significantly higher levels of hypertension, heart failure, chronic kidney disease, cerebrovascular disease, liver disease and obesity compared to patients admitted before the pandemic (Table 3) . During the first wave, COVID-19 admissions had significantly higher rates of diabetes, chronic pulmonary disease, obesity, and dementia, but lower rates of non-metastatic and metastatic cancer than non-COVID-19 admissions (Table 4 ).

Incident rates for ED attendances with low or lowmedium NEWS2 severity score decreased significantly during the pandemic first waves, but there was no change in the incident rates for patients with medium or high severity scores ( Table 5 , Fig. 4A ). Figure 4A demonstrates a small drop in low severity cases across the second wave with a rise in low severity cases in the summer of 2021. The overall mean severity score was 2.02 in the prepandemic period and 2.38 in the pandemic period for the whole of ED (p value < 0.001, Supplementary Table 3) . A greater number of ED attendances required supplemental oxygen on presentation in the pandemic first wave period compared to the matched period in 2019 (4.4% vs 7.3%, p < 0.001, Supplementary Table 3 ).

The number of medical admissions fell significantly across all severity categories for non-COVID-19 diagnoses during the first wave of the pandemic compared to the matched period of the previous year (Fig. 4B , Table 6 ). Figure 4B shows a marked fall in low severity cases in the first and second waves of the pandemic, with severity trends rising thereafter to pre-pandemic levels. The mean severity score for medical admissions fell from 3.7 in the previous year to 3.18 for non-COVID-19 admission in the first wave (p < 0.001) but was increased at 4.49 for COVID-19 admissions in the first wave (p < 0.001, Supplementary 

During the first wave of the pandemic, the number of ED attendances with shortness of breath as the presenting complaint increased by 58% (Fig. 5A, Table 7 ). Of the 10 commonest presenting complaints, the others all decreased during the first wave except for falls (Table 7) . There was a marked reduction in trauma in both the first and second COVID-19 waves (Fig. 5) . Among the 10 commonest groups of primary diagnosis in ED, only respiratory diagnoses (inclusive of COVID-19) did not fall significantly during the first wave ( Table 8 ). Analysis of the most granular level of primary diagnosis demonstrated no reduction in the selected major diagnoses of cardiac arrests, pulmonary embolism, subarachnoid haemorrhage, acute renal failure, and diabetic ketoacidosis, but there were reductions in ST-elevation myocardial infarction, stroke, asthma, and vasovagal syncope (Table 9 ). There was a marked drop in the common diagnostic group of "not applicable" in the first wave followed by an overall increase in the summer 2021 (Fig. 5B) . In most cases, this referred to a diagnosis of "no abnormality detected" or "patient walked out" (Fig. 5C ). Attendances where the "patient walked out" fell to almost zero in the first wave and remained low until the summer of 2021 when they rose to the highest level (Fig. 5C) .

For medical admissions, the most common primary diagnosis during the pandemic first wave period was 'COVID-19, virus identified', whereas at other times it was 'pneumonia (unspecified organism)' (Fig. 6 , Table 10 ). The incidence of admissions for the other top 10 medical diagnoses, other than cerebral infarction, were significantly reduced during the first wave (Table 10) . Cerebral infarction showed a trend to higher levels than the pre-pandemic period in the final months of the study period (Fig. 6, Supplementary Fig. 1 ). There was a marked peak in pneumonia in the winter of 2019-2020 which was not repeated the following winter when there was a second COVID-19 wave (Fig. 6) .

The mean length of stay for all ED attendances fell from 3.8 h to 3.1 h in the pandemic first wave period (p < 0.001, Student's t test). For medical admissions, the mean length of stay was 6.2 days in the pre-pandemic period compared to 5.5 for non-COVID-19 admissions during the pandemic first wave (p < 0.001), and 9.6 days for COVID-19 admissions (p < 0.001 compared to non-COVID-19 first wave admissions).

For ED attendances, the mortality rate during ED attendance or an associated admission was 1.2% (290/ 23218) in the pre-pandemic period compared to 2.9% (430/14398) in the pandemic first wave period (p < 0.001). Among medical admissions the overall inpatient mortality rate was 6.9% (292/4242) in the pre-pandemic period and 8.1% (207/2556) in the pandemic period among non-COVID-19 patients (p = 0.06). During the pandemic first wave, the inpatient mortality rate was higher for COVID-19 admissions at 28% (137/488, p < 0.001 compared to non-COVID-19 first wave admissions). Figure 7 demonstrates a relatively stable number of admissions of patients who died in hospital of non-COVID-19 illness, but a reduction in both COVID-19 waves in the number of patients admitted who did not die during the admission (Fig. 7) . 

Beyond the direct effect of COVID-19 illness, there have been concerns that the pandemic has deterred hospital attendances for acute non-COVID-19 illness, triggering increased downstream mortality or morbidity due to late presentation of disease [7, 8, [26] [27] [28] [29] [30] . In the UK, despite an attenuation in the pandemic from the spring of 2021, hospitals have experienced unprecedented ED attendances over the usually quiet summer period. In this context, understanding how the pandemic influenced hospital attendance and admission and which groups were under or over-represented is important for future health and pandemic planning. As anticipated, ED attendances and medical admissions fell rapidly with the first UK death and the lockdown. In the UK, medical attendances are mostly referred by general practitioners or ED doctors and the rapid fall with the first wave suggests reduced referrals and/or a reduced acceptance rate. ED attendances and medical admissions fell less sharply in the second wave, despite higher numbers of COVID-19 cases and higher daily death rates, indicating acclimatisation to the pandemic by clinicians and patients.

ED attendances have a high proportion of young patients, whereas medical admissions have a high proportion of older patients [31, 32] . The fall in ED attendances by young patients during the pandemic reflects experience elsewhere and is likely multifactorial [26, 33] . In some areas, closure of higher education institutions will have prompted some students to return to their family homes [34, 35] . However, similar falls have been seen elsewhere and may be consistent with younger patients not attending ED with self-limiting conditions and possibly experiencing less minor trauma with reductions in some activities during the lockdown [7, 10] . The greatest relative reduction in medical admissions were in the oldest age groups possibly due to concerns about COVID-19 acquisition in hospital or about the futility of admission [36] .

The increase in co-morbidities among medical admissions without COVID-19 suggests that admission for highly co-morbid patients was not easily avoidable, whilst those with lower co-morbidities presumably remained in the community. Medical admission with COVID-19 had a distinct comorbidity profile compared to non-COVID-19 admissions. Metastatic cancer was less common, perhaps because these patients shielded themselves from infections or because of reduced referral or admission rates; there is evidence of increased non-COVID-19 cancer mortality in the community [37] . In contrast, the increased prevalence of dementia among COVID-19 admissions could reflect outbreaks in nursing homes or difficulty shielding effectively when reliant on external carers. Other factors with higher prevalence in COVID-19 admissions, such as obesity and diabetes, reflect known susceptibility factors for severe COVID-19 illness [38, 39] . The NEWS2 severity scoring system has been adopted by the NHS to highlight patients at high risk of clinical deterioration [40] [41] [42] [43] . The fall in lower severity ED attendances that we observed during the first wave is consistent with several other studies identifying the greatest reductions in low acuity attendances though these studies also identify some reductions in higher severity cases [44] [45] [46] . In a healthcare system in the Netherlands where there are generally fewer low acuity ED attendances, a 30% reduction in attendance was nevertheless still observed [28] . Reduced attendances among lower acuity ED patients may not be immediately harmful if they represent non-severe illness. However, the reductions we observed in medical admissions across all severity categories suggests that some patients with severe illness did not attend hospital.

Several factors might have contributed to the steady rise in low severity ED attendances after the second peak, including diminished concern about acquiring COVID-19 in hospital, especially in the vaccinated, publicity about the dangers of avoiding acute care, increased exercise and traffic trauma, symptoms of long COVID-19 and a perceived reduction in access to primary care which has experienced increased demand in additional to providing vaccines. Delayed presentations of major illness might be expected to result in greater numbers of patients with higher severity scores subsequently, but this was not observed. Nor was there an increase in cardiac arrest presentations, although this may have been influenced by increased attention to resuscitation status during the pandemic [47] . The marked reduction in ED attendances for trauma during the first wave likely reflects in part reduced physical activity, sport, and road traffic. UK road traffic dropped by 59% and a Spanish trauma unit described significant reduction in most trauma [48, 49] . The common ED diagnoses of 'no abnormality detected' dropped substantially during each COVID-19 peak, which is unlikely to have led to clinical harm and may suggest scope for reducing ED attendances in the future. During the first wave, there were almost no ED attendances where the patient walked out and walk-outs remained low for some time thereafter. This might reflect a faster ED service, as length of ED stay was reduced, or resulted from nonattendance of people with low severity complaints. Walkouts increased in the summer of 2021 in association with increased ED attendances.

There were no changes in ED attendances during the pandemic for certain conditions that might be acutely disabling, such as subarachnoid haemorrhage or diabetic ketoacidosis. Other centres observed either a reduction or no change in sub-arachnoid haemorrhage [50, 51] . In aggregate, there were reductions in cardiac diagnoses and at a granular level there were reductions in atrial fibrillation as well as myocardial infarction, with potential downstream consequences, for example if fewer people with atrial fibrillation received stroke preventing anticoagulants. We observed no change in cerebral infarction strokes during the first wave, although a study in Israel found a reduction of 29% for stroke and a UK-wide registry study found only a 12% reduction in stroke admissions at the peak of the first wave [52, 53] . Our data suggest a possible trend towards increased strokes in the last months of our analysis which, if confirmed over time, might reflect reduced opportunities for stroke prevention during the pandemic. Medical admissions for myocardial infarction, with and without ST-elevation, were reduced during the pandemic and this is consistent with reports from the UK and elsewhere [7, 9, [54] [55] [56] . The relatively constant inpatient mortality for non-COVID-19 medical admissions throughout the study might suggest that in our catchment area similar numbers of patients with the most severe life-threatening non-COVID-19 conditions were attending hospital throughout. However, nationally there is evidence of reductions in hospital mortality with concomitant increases in community mortality [37] . There are necessarily limitations to any retrospective study, and we cannot determine the precise factors that influenced whether a patient attended hospital and then was or was not admitted. ED diagnoses are provided by the initial clinician, often a junior clinician, and therefore may not be as robust as the diagnoses for medical admissions, which are ratified retrospectively by professional coders. The NEWS2 score had not yet been fully adopted by our institution during the first wave of COVID-19, so scores were not explicitly available to clinicians and were calculated retrospectively.

The overall reduction in non-COVID-19 related acute presentations suggests both opportunities for reducing unnecessary ED attendances for those with low severity illness in the future, but also the possibility of harm from delayed or missed care. Trends to increased attendances and admissions during the recent summer 2021 period raise the possibility of further healthcare challenges, but also provide some reassurance that any deterrent effect on attendance is waning.

The online version contains supplementary material available at https://doi. org/10.1186/s12873-021-00529-w.

Additional file 1. Supplementary Information -Additional tables for ED and medical admissions comprising absolute numbers with proportions for age, ethnicity, deprivation status, Oxygen usage and NEWS2 score. Supplementary figure 1 primary diagnosis for medical admissions split into individual panels for each diagnosis.

Additional file 2. Supplementary file ECDS data -Spreadsheet of emergency care dateset diagnoses and grouping structure.

Coronavirus (COVID-19) in the UK

Covid-19: all non-urgent elective surgery is suspended for at least three months in England

Second Phase of NHS response to COVID-19: Letter from Simon Stevens and Amanda Pritchard

Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response

COVID-19 testing, epidemic features, hospital outcomes, and household prevalence

Mortality, admissions, and patient census at SNFs in 3 US cities during the COVID-19 pandemic

Admissions to veterans affairs hospitals for emergency conditions during the COVID-19 pandemic

Non-COVID-19 patients in times of pandemic: emergency department visits, hospitalizations and cause-specific mortality in northern Italy

The effect of the COVID-19 pandemic on emergency department visits for serious cardiovascular conditions

Effect of the COVID-19 pandemic lockdown on non-COVID-19 emergency department visits in eastern France: reduced risk or avoidance behavior

Process of care and activity in a clinically inclusive ambulatory emergency care unit: progressive effect over time on clinical outcomes and acute medical admissions

NHS Digital 2021

The Personal Demographics Service

Differential occupational risks to healthcare workers from SARS-CoV-2 observed during a prospective observational study

R: A language and environment for statistical computing

zoo: S3 Infrastructure for Regular and Irregular Time Series

Tools for Data Diagnosis, Exploration

Rstatix: pipe-friendly framework for basic statistical tests 0.7.0. 2021. software available at

Census Geography

English Indices of Deprivation 2015 -LSOA Level, viewed 12

comorbidity: An R package for computing comorbidity scores

Identifying increased risk of readmission and in-hospital mortality using hospital administrative data: the AHRQ Elixhauser comorbidity index

Package mfx marginal effects, odds ratios and incidence rate ratios for GLMs

Comorbidity measures for use with administrative data

Impact of the COVID-19 pandemic on emergency department visits -United States

Reduced emergency department utilization during the early phase of the COVID-19 pandemic: viral fear or lockdown effect

Trends in emergency department visits and hospital admissions in health care systems in 5 states in the first months of the COVID-19 pandemic in the US

Imperial College London

NHS Digital 2020

Impact of the SARS-CoV-2 pandemic and associated lockdown measures on attendances at emergency departments in English hospitals: a retrospective database study

Recommendations for future university pandemic responses: what the first COVID-19 shutdown taught us

The impact of COVID-19 on the undergraduate medical curriculum

The impact of the COVID-19 pandemic on hospital admissions in the United States. Health Aff (Millwood)

Place and Underlying Cause of Death During the COVID-19 Pandemic: Retrospective cohort study of 3.5 million deaths in England and Wales

Clinical findings of patients with coronavirus disease 2019 in Jiangsu province, China: a retrospective, multi-center study

Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis

Distributions of the National Early Warning Score (NEWS) across a healthcare system following a large-scale roll-out

Predictive value of National Early Warning Score 2 (NEWS2) for intensive care unit admission in patients with SARS-CoV-2 infection

A comparison of the quick sequential (Sepsis-related) organ failure assessment score and the National Early Warning Score in non-ICU patients with/without infection

Underutilization of the emergency department during the COVID-19 pandemic

The attend study: a retrospective observational study of emergency department attendances during the early stages of the COVID-19 pandemic

Delayed emergencies: the composition and magnitude of non-respiratory emergency department visits during the COVID-19 pandemic

Bringing into focus treatment limitation and DNACPR decisions: how COVID-19 has changed practice

Vivacity 2020. COVID-19 -Impact on Travel 23rd

Impact of the COVID-19 pandemic on an emergency traumatology service: experience at a tertiary trauma Centre in Spain

Decrease in hospital admissions for transient ischemic attack, mild, and moderate stroke during the COVID-19 era

Impact of COVID-19 pandemic on subarachnoid hemorrhage

Reduction in Acute Stroke Admissions during the COVID-19 Pandemic: Data from a National Stroke Registry

Stroke Care in the United Kingdom during the COVID-19 pandemic

The Covid-19 pandemic and the incidence of acute myocardial infarction

Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era

COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations

We would like to thank Alex Clift in the information team for assistance with electronic data queries.

Authors' contributions MR, CAO designed the study, analysed the data and wrote the manuscript. JB, AN, MG, SS, DL reviewed and edited the manuscript. All authors have read and approved the manuscript.

The research was supported by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. The funder had no role in the in the design of the study, data collection, analysis, and interpretation of data and in writing the manuscript.

The raw data analysed during the current study are not publicly available to avoid any possibility of identification of local patients, but aggregated or limited data may be available from the corresponding author on reasonable request.

Ethics approval and consent to participate The study formed part of an institutional service evaluation using retrospectively collected anonymized routine clinical data and was deemed not to require further ethical approval or informed consent from patients in accordance with the NHS Human Research authority guidelines. The requirement for informed consent was therefore waived.

All authors give consent to publish the manuscript.

The authors declare that they have no competing interests.